Longeveron Inc (LGVN) Stock Price, Quote, News & History

LGVNNASDAQ
$0.8000
-0.0004-0.05%
At close: Jun 23, 5:00 PM EST
$0.8000
N/A
After Hours: 9:10 AM EST

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-18.32M
Investing Cash Flow (TTM)
-465.00K
Financing Cash Flow (TTM)
20.21M
Free Cash Flow (TTM)
-18.78M
Capital Expenditure (TTM)
-465.00K
Net Change in Cash (TTM)
1.43M

Analyst Trends and Forecast

1
May
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$10.58M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
13.34
PB Ratio (TTM)
1.60
Earnings Yield % (TTM)
-140.76%
Earnings Yield % (FWD)
-80.26%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$0.51

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$15.76M
Debt to Equity
0.05
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$0.80
Close
$0.80
Volume / Avg.
129.68K / 547.77K
Day Range
$0.80 - $0.85
52 Wk Range
0.48 - 1.80
Market Cap
$25.28M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
51
Short Interest
7.38%
Days to Cover
5.31

About

Sector
Health Care
Industry
Biotechnology
Longeveron Inc is a clinical stage biotechnology company developing regenerative medicines to address unmet medical needs. Its investigational product candidate is laromestrocel. Laromestrocel is a proprietary, scalable, allogeneic cellular therapy t...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Longeveron (LGVN) stock?

A

You can purchase shares of Longeveron (NASDAQ:LGVN) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Longeveron (LGVN) competitors?

A

There are no as such competitors for Longeveron.

Q

What is the forecast, or price target, for Longeveron (LGVN) stock?

A

Longeveron has a consensus price target of $7.00.

Q

What is the current price for Longeveron (LGVN)?

A

The stock price for Longeveron (NASDAQ: LGVN) is $0.8 last updated June 23, 2026 at 9:10 AM EDT.

Q

Does Longeveron (LGVN) pay a dividend?

A

There are no upcoming dividends for Longeveron.

Q

When is Longeveron (NASDAQ:LGVN) reporting earnings?

A

Longeveron does not have any upcoming earnings scheduled.

Q

Is Longeveron (LGVN) going to split?

A

There is no upcoming split for Longeveron.

Q

What sector and industry does Longeveron (LGVN) operate in?

A

Longeveron is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.